Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Apr 15;395(2):233-8.
doi: 10.1042/BJ20051002.

Ca2+ release triggered by NAADP in hepatocyte microsomes

Affiliations

Ca2+ release triggered by NAADP in hepatocyte microsomes

Miklós Mándi et al. Biochem J. .

Abstract

NAADP (nicotinic acid-adenine dinucleotide phosphate) is fast emerging as a new intracellular Ca2+-mobilizing messenger. NAADP induces Ca2+ release by a mechanism that is distinct from IP3 (inositol 1,4,5-trisphosphate)- and cADPR (cADP-ribose)-induced Ca2+ release. In the present study, we demonstrated that micromolar concentrations of NAADP trigger Ca2+ release from rat hepatocyte microsomes. Cross-desensitization to IP3 and cADPR by NAADP did not occur in liver microsomes. We report that non-activating concentrations of NAADP can fully inactivate the NAADP-sensitive Ca2+-release mechanism in hepatocyte microsomes. The ability of thapsigargin to block the NAADP-sensitive Ca2+ release is not observed in sea-urchin eggs or in intact mammalian cells. In contrast with the Ca2+ release induced by IP3 and cADPR, the Ca2+ release induced by NAADP was completely independent of the free extravesicular Ca2+ concentration and pH (in the range 6.4-7.8). The NAADP-elicited Ca2+ release cannot be blocked by the inhibitors of the IP3 receptors and the ryanodine receptor. On the other hand, verapamil and diltiazem do inhibit the NAADP- (but not IP3- or cADPR-) induced Ca2+ release.

PubMed Disclaimer

Figures

Figure 1
Figure 1. NAADP-induced 45Ca2+ release from active loaded hepatocyte microsomes
(A) The time course of the Ca2+ uptake by liver microsomes was determined using 45Ca2+, as described in the Materials and methods section. Accumulation (■) of Ca2+ was started by addition of 1 mM ATP. The amount of mobilizable Ca2+ was determined by adding 5 μM ionomycin (arrow) to the medium. The effect on 45Ca2+ uptake of 1 μM thapsigargin (△) and 1 μM bafilomycin A1 (□) was also tested. Bafilomycin A1 was added to the microsomes 5 min before 45Ca2+ uptake was initiated. (B) Comparison of the Ca2+-mobilizing characteristics of IP3 (○), cADPR (●) and NAADP (▼) (10 μM each). CICR (▽) was determined by adjusting extravesicular free Ca2+ levels to pCa 6 using EGTA (100 μM). Results are means±S.E.M. for six to twelve determinations on at least four different experimental days. The inset shows the total amount of Ca2+ efflux triggered by IP3, cADPR and NAADP after 5 s of Ca2+ release. (C) Microsomes sequestered Ca2+ in the presence of an ATP-regenerating system (2 units/ml creatine-kinase and 4 mM phosphocreatine) and released calcium in response to subsequent addition of cADPR (●, 10 μM), IP3 (○, 10 μM) and NAADP (▼, 10 μM).
Figure 2
Figure 2. Dose-dependence of the NAADP-induced Ca2+ release in rat liver microsomes
Microsomes were actively loaded with Ca2+ in the presence of 1 mM ATP and were assayed for Ca2+ release using different concentrations of NAADP in the range 0.01–10 μM. Results are means±S.E.M. for five independent experiments.
Figure 3
Figure 3. Unique homologous desensitization pattern of the NAADP receptors
(A) Homologous desensitization of NAADP receptors by subthreshold concentrations of NAADP. Actively loaded microsomes (●) were pre-treated with 0.1 μM NAADP for 2 min (starting 3 min after uptake was initiated, indicated by the arrow) and were then challenged to a supramaximal concentration of NAADP (10 μM, ○). NAADP-induced Ca2+ release from non-pre-treated microsomes (▼). The inset shows the Ca2+ efflux at 5 min of Ca2+ loading from microsomes incubated with non-activating concentrations of NAADP and non-pre-treated microsomes. (B) Dose–response curve of NAADP (●) and the residual Ca2+ release by a supramaximal concentration of NAADP (10 μM) after 2 min of pre-incubation with concentrations of NAADP between 0.1 nM and 10 μM (○).
Figure 4
Figure 4. Effects of thapsigargin and bafilomycin A1 on the cADPR- and NAADP-elicited Ca2+ release in rat liver microsomes
The actively loaded vesicles were pre-incubated with thapsigargin (1 μM) for at least 2 min and with bafilomycin A1 (1 μM) for at least 5 min before Ca2+ release was induced with supramaximal concentrations of cADPR and NAADP (both 10 μM). Closed bars represent the Ca2+ release from non-pre-treated microsomes, while open bars show the Ca2+ efflux from microsomes treated with thapsigargin (1 μM) and hatched bars represent the effect of bafilomycin A1 (1 μM).
Figure 5
Figure 5. Ca2+- and pH-dependence of the NAADP-induced Ca2+ release
(A) Extravesicular free Ca2+ concentration-dependence of the IP3-, cADPR- and NAADP-mediated system in passively loaded liver microsomes. Extravesicular pCa (4–8) was set by EGTA (200–750 μM), NAADP (■), IP3 (◆) and cADPR (□) were applied at supramaximal concentrations (10 μM). (B) Differential effect of pH on the cADPR- and NAADP-sensitive Ca2+-releasing system. The pH of the Ca2+-release medium was changed from 6.4 to 7.8, and the amount of 45Ca2+ released by 10 μM cADPR (□) and 10 μM NAADP (■) was determined.
Figure 6
Figure 6. Pharmacological properties of the intracellular Ca2+ channels mediated by IP3, cADPR and NAADP
The 45Ca2+ release by supramaximal concentrations of IP3, cADPR and NAADP (all 10 μM) was challenged in the presence of heparin (100 μg/ml), ryanodine (5 μM), Ruthenium Red (5 μM), verapamil (100 μM) and diltiazem (100 μM).

Similar articles

Cited by

References

    1. Berridge M. J. Cell signalling: a tale of two messengers. Nature (London) 1993;361:315–325. - PubMed
    1. Lee H. C. Calcium signalling: NAADP ascends as a new messenger. Curr. Biol. 2003;13:R186–R188. - PubMed
    1. Patel S., Joseph S. K., Thomas A. P. Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium. 1999;25:247–264. - PubMed
    1. Lee H. C. Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu. Rev. Pharmacol. Toxicol. 2001;41:317–345. - PubMed
    1. Berridge M. J., Lipp P., Bootman M. D. The versatility and universatility of calcium signalling. Nature Rev. Mol. Cell Biol. 2001;1:11–21. - PubMed